Japan Vietnam Medical Investment and Development JSC (HOSE:JVC)

HOSE:JVC Financials Overview

Financials in millions VND. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Jun 30, 2026	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Mar 31, 2017	Mar 31, 2016
Revenue Revenue Growth	747,221	763,153	611,540	576,287	499,432	507,338
Revenue Growth	14.41%	24.79%	6.12%	15.39%	-1.56%	-43.20%
Gross Profit Gross Profit Growth	165,318	148,917	147,572	138,863	93,981	3,386
Operating Income Operating Income Growth	62,675	52,796	36,510	27,308	-26,745	-1,192,003
Net Income Net Income Growth	50,502	49,945	40,282	52,634	-31,694	-1,335,782
Earnings Per Share EPS Growth	448.90	443.96	358.00	467.86	-281.73	-11873.60
EPS Growth	-3.36%	24.01%	-23.48%	-	-	-

Revenue by Segment

Chart

Fiscal Year	TTM	FY 2025	FY 2024
Period Ending	Jun 30, 2026	Dec 31, 2025	Jan 1, 2025
Sale of Goods Sale of Goods Growth	649,781	674,437	493,120
Providing Services Providing Services Growth	-	59,619	50,691
Medical Device Integration Activities Medical Device Integration Activities Growth	-	29,097	67,729
Total Total Growth	747,221	763,153	611,540

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Jun 30, 2026	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Mar 31, 2017	Mar 31, 2016
Cash & Investments Cash & Investments Growth	135,314	29,228	19,582	153,516	37,500	16,557
Total Debt Total Debt Growth	225,198	303,082	140,829	92,726	35,721	51,611
Net Cash (Debt) Net Cash Growth	-89,884	-273,854	-121,247	60,790	1,778	-35,054
Net Cash Growth	-	-	-	3318.23%	-	-
Net Cash Per Share Net Cash Per Share Growth	-798.97	-2434.25	-1077.75	540.36	15.81	-311.59

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Jun 30, 2026	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Mar 31, 2017	Mar 31, 2016
Operating Cash Flow Operating Cash Flow Growth	274,041	-88,546	85,753	-6,474	76,126	-319,023
Capital Expenditures CapEx Growth	-19,918	-41,862	-16,594	-43,363	-42,587	-8,810
Free Cash Flow Free Cash Flow Growth	254,123	-130,408	69,159	-49,837	33,540	-327,834
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Jun 30, 2026	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Mar 31, 2017	Mar 31, 2016
Gross Margin	22.12%	19.51%	24.13%	24.10%	18.82%	0.67%
Operating Margin	8.39%	6.92%	5.97%	4.74%	-5.36%	-234.95%
Pretax Margin	8.33%	8.05%	9.63%	9.70%	-5.94%	-263.34%
Profit Margin	6.76%	6.54%	6.59%	9.13%	-6.35%	-263.29%
FCF Margin	34.01%	-17.09%	11.31%	-8.65%	6.72%	-64.62%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2017	FY 2016
Period Ending	Oct 14, 2026	Dec 31, 2025	Jan 1, 2025	Jan 1, 2024	Mar 31, 2017	Mar 31, 2016
PE Ratio	6.22	13.72	10.61	7.22	-	-
Forward PE	-	9.64	9.64	9.64	9.64	9.64
P/FCF Ratio	1.24	-	6.18	-	11.64	-
PS Ratio	0.42	0.90	0.70	0.66	0.78	1.02

Data Source: S&P Global Market Intelligence Last updated: Sep 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 14, 2026

Data Sources Report a data error